Canadian grants & funding programs

Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO), issued by the National Cancer Institute (NCI), is to invite competing continuation applications for cooperative agreement awards from current recipients of the NCI-supported Cooperative Human Tissue Network (CHTN).. CHTN with all individual CHTN recipients (referred to as CHTN Divisions) collectively form the CHTN national resource. Presently, the organizational structure of the Network comprises six Divisions.. The goal of the CHTN is to collect and distribute to investigators high-quality human tissue specimens to facilitate basic and translational cancer research. Such specimens may be needed for scientific discovery and the development of various molecular diagnostic tests, and prognostic or predictive assays. The CHTN is designed as a unique biospecimen resource in that it is based on the prospective collection and distribution of samples upon specific investigators requests. Samples to be collected from patients include pre-cancerous, malignant, and benign neoplastic tissues, as well as tissues with non-neoplastic diseases and normal tissues. Since its establishment by the NCI in 1987, the CHTN has provided more than 1,350,000 malignant, benign, diseased, and uninvolved (normal adjacent) high-quality human tissue specimens from a wide variety of organ sites to over four thousand investigators.

United States

Team Grant: Improving Health and Administrative Data and Monitoring for Rare Diseases

75% funding for health research, knowledge translation, and commercialization projects.

The current administrative coding system used in Canada, the International Classification of Diseases (ICD)-10-CA, only includes coding for a small fraction of the over 7000 known rare diseases. This prevents determination of the actual cost of diagnosis, care, and research of rare inherited diseases in Canada and impedes accurate estimation of the level of required investment. Retrospective studies from other countries suggest that rare/inherited diseases as a disease class currently account for the highest proportion of pediatric mortality and hospital bed occupancy, as well as the highest direct cost to the pediatric health care system.. . To address this issue, the Orphanet Initiative developed the ORPHAcodes, a coding system that provides a unique identifier to each rare disease. In collaboration with Orphanet, the World Health Organization integrated the ORPHAcodes in the revision of ICD-10, resulting in the ICD-11 classification, which now allows tracking of rare diseases in administrative databases. However, this new system is not yet implemented in Canada.

Canada

Team Grant: Lung Health

I couldn't find specific details about the grant funding percentage and eligible expenses from the provided links. Therefore, I cannot create an accurate tagline based on the grant's actual offerings. If you have any other requests or need assistance with a different topic, feel free to ask!

All Canadians, across the lifecycle, are affected by the quality of the air we breathe, both indoors and outdoors. Inhalation of gases and toxins resulting from, but not limited to, smoking, vaping, radon and air pollution can significantly impact the health of the lungs and other organ systems, such as the heart and brain. Resultant absorption of particulate matter and aerosol pollutants can damage lung tissue directly and cause local and systemic inflammation throughout the body. Considering the ongoing, new and emerging threats to lung health, such as lung cancers among people who have never smoked, the effects of vaping on health, viral infections (e.g., SARS-CoV-2), and the impacts of climate change, there is an urgent need for strategic investment in lung health.. . Across the lifecycle, particularly at the extremes of age (the very young and very old), individuals are vulnerable to the impact of poor air quality. Poor air quality (through air pollution, climate emergencies, and atmospheric inversions) has been linked to preventable emergency department (ED) visits, hospitalizations and even deaths. A diverse range of serious cardiovascular and respiratory conditions have been shown to increase within three days of increases in ozone, sulfur dioxide, nitrous oxide and carbon monoxide as measured through the Air Quality Health Index (AQHI). The pathophysiology of these resultant conditions is thought to be related to systemic inflammation, so it is perhaps not surprising that other inflammatory conditions such as stroke, heart attacks, infections, and headache can increase with poor air quality measures.. . Moreover, cigarette smoking and vaping are estimated to contribute significantly to preventable deaths, hospitalizations and ED visits. The recent dramatic rise in vaping among youth who have never smoked, along with the E-cigarette and Vaping Products Acute Lung Injury (EVALI) crisis in the US and Canada prior to the pandemic, reflect the need to continue examining the health effects of vaping. While cigarette smoking has been linked to lung and multiple other cancers, lung cancers in people who haven't smoked are increasing, and the role of lung toxins in the etiology of these cancers requires additional investigation. Over time, the accumulated toxic load on the lung from ongoing exposure to environmental pollutants, such as smoking, vaping and poor air quality, becomes unsustainable and result in detrimental health effects on the lung. For individuals with underlying and/or active lung disease, these exposures result in increased symptom burden and morbidity.. . Finally, there are inequitable impacts on lung health connected from geographical location, social status, ancestral heritage, sex, gender, sexual orientation and age. For example, it is becoming more common for people residing in remote, rural and northern communities to be adversely affected by poor air quality caused by wildfires. Women generally are both under-represented in research and mis-diagnosed for cardio-respiratory conditions, suggesting that sex and gender considerations are in urgent need of attention. Moreover, Indigenous Peoples (First Nations, Inuit and Métis) in Canada are at risk of greater exposure to toxins in their lungs due to higher smoking rates, crowded/poor housing and environmental factors that affect air and water quality. Interestingly, current evidence suggests there are wide differences between First Nations, Inuit and Métis populations related to rates of detection for various lung health conditions.. . The goal of this funding opportunity is to unite interdisciplinary Research Teams to collectively address threats to lung health in a manner that leverages past investments, existing capacity, available infrastructure and research expertise.

Canada

Digital Citizen Contribution Program

75% funding for research, tools, and activities to combat online disinformation.

The Digital Citizen Contribution Program supports the priorities of the Digital Citizen Initiative by providing time-limited financial assistance for research and citizen-focused activities. The Program aims to support democracy and social inclusion in Canada by enhancing and/or supporting efforts to counter online disinformation and other online harms and threats.

Canada

Partners for Fish and Wildlife FY23

The Partners for Fish and Wildlife (PFW) Program is a voluntary, incentive-based program that provides direct technical assistance and financial assistance in the form of cooperative and grant agreements to private landowners to restore and conserve fish and wildlife habitat for the benefit of federal trust resources. The PFW Program is delivered through more than 250 full-time staff, active in all 50 States and territories. Partners for Fish and Wildlife Program staff coordinate with project partners, stakeholders and other Service programs to identify geographic focus areas and develop habitat conservation priorities within these focus areas. Geographic focus areas define where the program directs resources to conserve habitat for federal trust species. Project work plans are developed strategically, in coordination with partners, and with substantial involvement from Service field staff. The program has been in existence since 1987 and has over 30 years of successful delivery. Project selection will seek to align or support the Secretary’s priorities. It also advances the Department of the Interior’s mission, U.S. Fish and Wildlife Service’s mission, and PFW’s mission, promote biological diversity, and based upon sound scientific biological principles. Program strategic plans inform the types of projects funded under this opportunity.. . Applicants seeking technical or financial assistance from the PFW Program are requested to consult with a local PFW Program office BEFORE developing or submitting an application (see Agency Contacts at the end of this announcement or visit https://www.fws.gov/program/partners-fish-and-wildlife/contact-us

United States

CCRP Initiative: Chemical Threat Agent Exposure Resource and Coordination Core (ExRC) (U2C Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support a Chemical Exposure Resource and Coordination Core (ExRC) that will provide infrastructure, management, and research support for studies of Chemicals of Concern (CoC) to the Chemical Countermeasures Research Program (CCRP). This core, established across diverse geographical regions, is intended to support multidisciplinary CCRP investigators, through development of infrastructure and exposure protocols for selected toxicants. The ExRC will provide facility access for using diverse models to characterize pathophysiological mechanisms and evaluating potential medical countermeasures through early-stage development efforts supported by the CCRP.

United States

Notice of Intent to Publish a Notice of Funding Opportunity for National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)

The purpose of this notice is to inform the research community that the National Institute of Biomedical Imaging and Bioengineering (NIBIB) intends to reissue a Notice of Funding OpportunityÔř? PAR-20-169Ôř?Ôř?"National Centers for Biomedical Imaging and Bioengineering (NCBIB) Ôř?(P41 Clinical Trials Optional)."Ôř?. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.Ôř?. The NOFO is expected to be published in late summer 2023 with an expected application due date in fall 2023.. This NOFO will utilize the P41 activity code. Details of the planned NOFO are provided below.Ôř?Ôř?

United States

Research Grants to Identify Effective Community-Based Strategies for Overdose Prevention (R01)

The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC, Injury Center) is soliciting investigator-initiated research to partner with communities to develop and rigorously evaluate the effectiveness of new, innovative, under-developed, or untested community-based strategies/interventions/programs/practices to reduce overdose. Strategies/interventions/programs/practices may include, but are not limited to, those that focus on preventing drug use initiation and drug use, reducing non-infectious harms related to drug use, reducing stigma or other barriers to harm reduction or substance use disorder treatment, and increasing linkage to and retention in care. Research should focus on groups experiencing disproportionate burden of overdose and/or groups that are at greater risk of experiencing adverse outcomes related to substance use.  Research should also involve engaging individuals in the focus population (e.g., people with lived experience with substance use). 

United States

Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required)

Under the Ending the HIV Epidemic (EHE) initiative, the National Institute on Drug Abuse (NIDA) is releasing a set of interrelated RFAs to create the HIV/Justice Research Network, a coordinated effort to study innovative strategies to promote improvements in HIV prevention and treatment services for individuals involved in the criminal legal system with substance use disorder (SUD). Separate FOAs are being issued to support three components: multiple Regional Research Hubs (RRH; RFA-DA-24-015); one Data Coordination and Dissemination Center (RFA-DA-24-023); and one Patient Engagement Resource Center (PERC; RFA-DA-24-022). It is imperative that prospective applicants read all of these related FOAs to better understand the intended purpose and structure of the HIV/Justice Research Network.. This FOA seeks applications for multiple Regional Research Hubs. These phased awards will partner with the criminal legal system and HIV/SUD service providers in 3 or more communities to field pilot studies and hybrid implementation-effectiveness trials testing innovative service delivery models to better engage populations involved in the criminal legal system in HIV and SUD prevention, treatment, recovery, and harm reduction.

United States

HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain(R01 Clinical Trial Not Allowed)

This funding opportunity announcement (FOA) invites research to develop, characterize, and rigorously validate non-rodent mammalian models of pain, associated outcome measures and/or endpoints that enable translational research for effective pain management. These models are expected to recapitulate molecular, cellular, pathological, behavioral, and/or cognitive aspects of human pain disorders and conditions. Research supported under this FOA is expected to provide well-validated models and measures that facilitate the development of non-opioid analgesic therapeutic interventions with little or no addiction liability.

United States

Roybal Centers for Translational Behavioral Research on Dementia Care, Caregiver Support, and Prevention of Alzheimers Disease and Related Dementias (AD/ADRD) (P30 Clinical Trial Required)

This Funding Opportunity Announcement (FOA) solicits Edward R. Roybal Centers for translational intervention development research for Alzheimers Disease and Alzheimers Disease related dementias care provider support. The purpose of the Roybal Centers is to develop behavioral interventions that improve the health, well-being and/or capacity of individuals and/or systems that provide care to persons with AD-ADRD. Roybal Centers will conduct Stage 0 through IV pilot studies in accordance with the multidirectional, translational NIH Stage Model, to produce potent and implementable principle-driven behavioral interventions.

United States

Sexual Risk Avoidance Education Program

The Administration for Children and Families, Administration on Children, Youth and Families, Family and Youth Services Bureau announces the availability of funds under the Sexual Risk Avoidance Education (SRAE) Program.  The purpose of the SRAE Program is to fund projects to implement sexual risk avoidance education that teach participants how to voluntarily refrain from non-marital sexual activity.  The services are targeted to participants that reside in areas with high rates of teen births and/or are at greatest risk of contracting sexually transmitted infections (STIs). The goals of SRAE are to empower participants to make healthy decisions, and provide tools and resources to prevent pregnancy, STIs, and youth engagement in other risky behaviors.  Successful applicants are expected to submit program plans that agree to 1) use medically accurate information referenced to peer-reviewed publications by education, scientific, governmental or health organizations; 2) implement sexual risk avoidance curricula and/or strategies with an evidence-based approach to integrate research findings with practical implementation that aligns with the needs and desired outcomes for the intended audience; and 3) teach the benefits associated with self-regulation, success sequencing for poverty prevention, healthy relationships, goal setting, resisting sexual coercion, dating violence, and other youth risk behaviors such as underage drinking or illicit drug use without normalizing teen sexual activity. 

United States

HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)

This RFA will act as a parent RFA for the HEAL initiative Translation to Practice Team, specifically encouraging translational dissemination and implementation research focused on addressing overdose deaths and the intersection of pain and OUD. This RFA will function in tandem with targeted NOSIs that announce more specific areas of focus. For FY23, this currently includes the Workforce NOSI (formerly an RFA) and the Violence and Trauma NOSI (also formerly an RFA). It has a companion R33 RFA and is expected to run for 2 years (FY23 and FY24).

United States

Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)

Reissue PAR-19-220.

United States

Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings

The purpose of this notice of funding opportunity (NOFO) is to investigate the feasibility, effectiveness, and cost-effectiveness of high-quality and innovative public health interventions to improve glaucoma detection and management among high-risk populations within community-based health care delivery settings. This NOFO has two components:Component A: Comparative effectiveness trials of community-based interventions in high-risk populations in diverse locations. Communities include populations living with undiagnosed eye diseases due to lack of access, resources, vision specialists, etc. Award recipients are expected to collaborate to establish a standard investigative protocol.Component B:  A coordinating center to provide data storage (if needed), harmonize data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.Glaucoma is one of the leading causes of irreversible blindness in the United States, and the leading cause of blindness among African Americans. Of an estimated 2.7 million people with glaucoma, 50% of them are unaware of their condition. Given the low prevalence in the general population, this NOFO focuses on people at high-risk for glaucoma and does not include broad general screening programs.In the past decade, large-scale glaucoma studies funded by CDC among high-risk groups have demonstrated success in screening and follow-up care to slow disease progression through innovative delivery programs. CDC intends to further this research by funding projects with strategies that are cost-effective, comprehensive, and include allied health care professionals (e.g. community healthcare workers, ophthalmic technicians, navigators); mobilize community partners and resources; use advanced technological approaches; demonstrate potential for adoption into real-world clinical practice; and have the greatest potential to affect population health, public policy, and implementation.

United States

Community Tourism Destination Development Fund

75% funding for tourism projects, enhancing services and infrastructure in your community.

The Community Tourism Destination Development Fund provides support to capital and non-capital projects that focus on sustainable tourism development in Yukon.

Yukon

HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to develop clinical-grade prototypes intended for use as safe, effective, and non-addictive device-based technologies and approaches to treat pain. The goal of the program is to demonstrate treatment using credible neural targets for device-based interventions and/or diagnostics for pain, building upon the latest mechanistic knowledge about the anatomy and physiology of central, spinal, and peripheral pathways involved in pain. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.

United States

HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)

This RFA will act as a parent RFA for the HEAL initiative Translation to Practice Team, specifically encouraging translational dissemination and implementation research focused on addressing overdose deaths and the intersection of pain and OUD. This RFA will function in tandem with targeted NOSIs that announce more specific areas of focus. For FY23, this currently includes the Workforce NOSI (formerly an RFA) and the Violence and Trauma NOSI (also formerly an RFA). It has a companion R61/R33 RFA and is expected to run for 2 years (FY23 and FY24)

United States

PARTENAR-IA – PRIMA – Academic

Get a non-refundable grant up to $350,000 to cover up to 50% of eligible expenses when your SME partners with a research centre on an artificial intelligence R&D project in the field of advanced materials.

Quebec

Collaborative Industrial Research and Support to Innovative Entrepreneurship – Stream 2

50% funding for AI innovation, R&D, and collaboration projects in Quebec.

The program provides funding for product or process innovation projects involving AI, from planning to real-life demonstration.

Quebec

Building Capacity for Chronic Disease Education and Awareness

The purpose of this 4-year NOFO is to fund approximately 4 applicants to expand and advance CDC’s work with stakeholders on education, outreach, and public awareness activities to strengthen the science base for prevention, education, and public health awareness for a variety of chronic diseases that do not currently have dedicated resources that would lead to meaningful patient outcomes. Stakeholders will focus on data dissemination, education, and public awareness activities that will support effective, evidence-based clinical and population-level approaches to improve health and health equity.

United States

Exploratory/Developmental Grants Related to the World Trade Center Survivors (R21-No Applications with Responders Accepted)

NIOSH supports exploratory and developmental research projects (R21) that address issues related to diagnostic or treatment uncertainty with respect to individuals receiving monitoring and/or treatment under subtitle B, of the James Zadroga 9/11 Health and Compensation Act of 2010 (Public Law 111‚Äě347, as amended by Public Laws¬†114‚Äě113¬†and¬†116‚Äě59).To help address the Zadroga Act research mandate, as supported by the World Trade Center (WTC) Health Program in consultation with the¬†WTC Health Program Scientific/Technical Advisory Committee, NIOSH is soliciting applications for scientifically rigorous research (42 U.S.C. ¬ß300mm‚Äě51) among enrolled certified-eligible WTC survivors and similarly exposed populations in New York City in Manhattan between Houston Street and 14th Street and in Brooklyn to help answer critical questions about:Physical and mental health conditions that may be related to the September 11, 2001, terrorist attacks;Diagnosing WTC-related health conditions for which there has been diagnostic uncertainty; andTreating WTC-related health conditions for which there has been treatment uncertainty.A major area of research interest of this announcement also includes improving the healthcare and well-being of at-risk survivor populations including minority groups, women exposed while pregnant or of reproductive age, the elderly, adolescents, and other minor children.Certified-eligible WTC survivors (adults and children) include individuals who lived, worked, went to school, or attended child or adult day care in the¬†New York City (NYC) Disaster Area, as defined in¬†42 CFR 88.1, on September 11, 2001, or in the following days, weeks, or months and those otherwise meeting the eligibility criteria in 42 CFR¬†88.7¬†or¬†88.8¬†who have been identified as eligible for medical monitoring and treatment as described in¬†42 CFR 88.1¬†or¬†88.12(b).In addition to certified-eligible WTC survivors, proposed research can include sampled populations outside the NYC disaster area in Manhattan as far north as 14th Street and in Brooklyn, along with control populations, to identify potential for long-term adverse health effects in less exposed populations.NIOSH/WTC Health Program R21 grants support the early and conceptual stages of research projects that assess the feasibility of novel areas of investigation, with the potential to enhance the effectiveness of treatment and diagnostic practice. These studies may lead to breakthroughs in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that have a major clinical impact. These studies should break new ground or extend previous discoveries toward new directions or applications. Applicants are expected to propose research approaches for which there is likely to be minimal or no preliminary data.

United States

Proof-of-Concept Program

The Proof of Concept Program supports projects that help to establish the commercial feasibility of innovative natural products or technologies to advance development, commercialization, or de-risk subsequent investment.

Canada

Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21)

NIOSH supports exploratory and developmental research projects (R21) that address issues related to diagnostic or treatment uncertainty with respect to individuals receiving monitoring and/or treatment under subtitle B, of the James Zadroga 9/11 Health and Compensation Act of 2010 (Public Law 111‚Äě347, as amended by Public Laws¬†114‚Äě113¬†and¬†116‚Äě59). Enrolled WTC responders and certified-eligible WTC survivors will be included in the research project.Lifestyle medicine is a highly valuable, evidence-informed clinical approach, focused on managing and reversing many of the types of chronic diseases certified as WTC-related health conditions by the WTC Health Program. By focusing on sustainable health behaviors and lifestyle factors (including six pillars: nutrition and diet, sleep hygiene, stress management and positive psychology, physical activity, social connectedness, and avoidance of substance misuse), lifestyle medicine has the potential to limit disease progression; to prevent development of additional chronic diseases; and to improve health outcomes, overall member well-being, quality of life, and member satisfaction with the Program.To establish the scope of the WTC Health Program FY2023 lifestyle medicine research, NIOSH seeks to achieve a suitable mix of projects and interventions focusing on sustainable health behaviors and the lifestyle factors described above. All of these sustainable health behaviors and lifestyle factors influence quality of life, disease progression and recurrence, survival, adverse events, and other health-related outcomes among WTC Health Program members.NIOSH/WTC Health Program R21 grants support the early and conceptual stages of research projects that assess the feasibility of novel areas of investigation, with the potential to enhance the effectiveness of treatment and diagnostic practice. These studies may lead to breakthroughs in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that have a major clinical impact. These studies should break new ground or extend previous discoveries toward new directions or applications. Applicants are expected to propose research approaches for which there is likely to be minimal or no preliminary data.

United States

Seed Funding Program

30% funding for early development costs: business plans, design, site assessments, and feasibility studies

Grant Goals - Provide financial support for early-stage affordable housing project development - Assist community housing providers in initial project planning and feasibility stages - Support innovative housing solutions across various housing types and communities - Facilitate predevelopment activities for new or renovated affordable housing projects Keywords - Seed funding - Affordable housing - Predevelopment support - Housing innovation - Community housing - Non-profit housing - Indigenous housing - Rental development - Housing feasibility - Project planning - Preliminary design - Site assessment - Affordable rental - Housing needs analysis - Social infrastructure - Community development - Housing sustainability - Accessibility modeling - Energy efficiency - Urban regeneration Description CMHC's Seed Funding program provides critical financial assistance to housing developers in the early stages of affordable housing project conception. The program offers up to $350,000 in interest-free loans and $150,000 in non-repayable contributions to support comprehensive predevelopment activities. Target Audience - Community housing providers - Public and private non-profit housing organizations - Rental co-operatives - Municipal governments - Provincial and territorial government agencies - Indigenous governments and organizations - First Nation bands - Tribal councils - Private entrepreneurs - Developers - Builders Eligible Expenses - Needs and demand analysis - Special purpose surveys - Preliminary financial feasibility studies - Business plan development - Incorporation costs - Option to purchase documentation - Security registration - Professional appraisals - Site surveys - Planning fees - Rezoning costs - Development agreement expenses - Preliminary design work - Project viability studies - Environmental site assessments - Geotechnical reports - Energy modeling - Accessibility studies - Cost-benefit analyses Eligibility - Minimum 5 affordable housing units - Primary residential use - Proposed rents must be affordable - Aligned with municipal/provincial/territorial housing standards - Projects serving housing needs of vulnerable populations Criteria - Economic sustainability - Housing for those in greatest need - Innovative housing solutions - Potential for community impact - Feasibility of proposed project - Alignment with local housing strategies Program Requirements - Maximum $350,000 interest-free loan - 3-year term to complete project - Loan can be combined with non-repayable contributions - Maximum $150,000 non-repayable contribution - Funding must be invoiced by December 31, 2025 - Adherence to CMHC terms and conditions Hiring Criteria - Not explicitly defined - Implied focus on housing development professionals - Expertise in affordable housing design - Understanding of community housing needs - Project management skills Due Dates - Continuous application process - Applications accepted starting March 1, 2025 - Funding to be spent by December 31, 2025 Start Dates - Flexible based on project readiness - No specific mandatory start date - Dependent on project approval and funding allocation Age Requirements - No specific age restrictions - Open to organizations and individuals Industry / Area of Work - Affordable housing - Community housing - Indigenous housing - Transitional housing - Supportive housing - Mixed-use residential development - Non-residential building conversion - Rental housing - Social infrastructure development

Alberta · British Columbia · Manitoba · New Brunswick +9 more

NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

The NIH Directors Pioneer Award Program supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative research towards the ultimate goal of enhancing human health. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigators research program or elsewhere. The NIH Directors Pioneer Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

United States

NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)

The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The OIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards. The OIA will support the research program of NHLBI-funded investigators for up to seven years. The OIA will provide investigators increased freedom to conduct research that breaks new ground or extends previous discoveries in new directions. It will also allow PD/PIs to take greater risks and to pursue research that requires a longer timeframe. Research supported by the OIA must be within the scope of the NHLBI mission (https://www.nhlbi.nih.gov/about/mission-statement). It is anticipated that the OIA will: Provide a stable funding environment, thereby improving productivity and facilitating nimble, ambitious, creative research; Accelerate scientific innovation by enabling flexibility in pursuing new research directions as they arise, since PD/PIs will not be bound to specific aims proposed in advance of the studies; Reduce the time researchers spend writing grant applications and managing multiple grant awards, thereby allowing more time to be devoted to conducting research; Facilitate PD/PIs commitment to research through increased stability of funding; and Enable PD/PIs to devote more time and energy to mentoring students and junior scientists and providing scientific service.

United States

Proof of Concept Program

Supports innovative natural products or technologies with up to 40% funding to a maximum of $350,000 for commercial feasibility.

Canada

Support for innovation projects

Get up to $350,000 to cover 75% of the costs of project planning, R&D, technology validation and technological showcase activities relating to the development of innovative products or processes. The program will cover a maximum of 30% of eligible costs for a single business, and 50% of eligible costs for a collaboration.

Quebec

NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)

The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research relevant to drug abuse and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. The term avant-garde is used to describe highly innovative approaches that have the potential to be transformative. The proposed research should reflect approaches and ideas that are substantially different from those already being pursued by the investigator or others and should support the NIH HIV/AIDS Research Priorities https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-018.html. The NIDA Avant-Garde award supports innovative, basic research that may lead to improved preventive interventions or therapies; creative, new strategies to prevent disease transmission; novel approaches to improve disease outcomes; and creative approaches to eradicating HIV or improving the lives of those living with HIV.

United States

Alberta Innovates - Product Demonstration Program

Supports technology companies in demonstrating innovative products in real-world settings. Funding up to $350,000 for demonstration projects.

Alberta

AgriAssurance Program: Kosher and Halal Investment Component

I was unable to access the grant page directly. However, if you provide me with the main details of the grant such as the percentage of funding, eligible expenses, and activities, I can create an exciting and accurate tagline for you.

Grant Goals - Support Canadian red meat processors - Enhance kosher and halal food processing capabilities - Promote export and market development - Facilitate cross-cultural food sector innovation - Improve international trade competitiveness Keywords - Kosher food processing - Halal meat certification - Agricultural investment - Food sector innovation - Export market development - Agri-food transformation - Cultural food standards - Meat processing efficiency - Trade capability enhancement - Sectoral adaptation - Culinary compliance - International market access - Food certification - Processor support - Agricultural technology Description The AgriAssurance Program: Kosher and Halal Investment Component is a strategic funding initiative designed to support Canadian red meat processors. The program aims to enhance food processing capabilities, promote cultural food standards, and expand international market opportunities. Target Audience - Red meat processors - Food manufacturing companies - Kosher and halal food producers - Agricultural sector entrepreneurs - Export-oriented food businesses - Small to medium-sized food processors Eligible Expenses - Equipment upgrades - Certification process improvements - Market research - Technology implementation - Processing facility modifications - Compliance system development - Export readiness initiatives Eligibility - Canadian-based red meat processors - For-profit organizations - Businesses with kosher/halal market potential - Demonstrated export readiness - Compliance with food safety regulations Program Requirements - Align with kosher/halal food standards - Demonstrate market development potential - Provide detailed implementation plan - Commit to export market expansion - Maintain food safety compliance Hiring Criteria - Food processing expertise - Cultural food standard knowledge - Export market understanding - Technical certification skills - Intercultural communication abilities Due Dates - Program period: 2025-26 to 2027-28 - Specific application windows to be announced Start Dates - Fiscal year 2025-26 - Flexible project implementation timeline Age Requirements - No specific age restrictions - Business maturity and operational history considered Industry / Area of Work - Red meat processing - Food manufacturing - Agricultural technology - Export-oriented food production - Cultural food certification - International trade development

Alberta · British Columbia · Manitoba · New Brunswick +9 more

NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)

This initiative invites applications for DP1 awards to support exceptionally creative early career investigators who propose high-impact projects that lead to advances in equity across populations affected by substance use-related harms. Investigators who apply may represent various fields of research, but research projects will emphasize persistent or intractable challenges that drive disparities in medical and other consequences related to substance use and SUD across population groups.

United States

PARTENAR-IA – PROMPT – Industry

The program is designed to provide a non-refundable grant up to $350,000 per partner company to cover up to 50% of the expenses when partnering on an AI project.

Quebec

PARTENAR-IA – CRIBIQ – Industry

The webpage is currently not accessible. I cannot retrieve the grant information directly. Please provide key details about the grant, such as the percentage of funding, eligible expenses, and activities, so I can help create an exciting tagline.

Le programme PARTENAR-IA | Entreprises vise ŕ : Améliorer la compétitivité des entreprises de la bioeconomie quebecoise grâce ŕ l'adoption de l'IA, particuličrement dans les secteurs oů elle est encore peu utilisée, tels les secteurs primaires et secondaires de l'économie ; Encourager les collaborations entre les entreprises (de toute taille, y compris les startups) ainsi qu'avec les milieux de la recherche et de l'innovation pour accélérer l'intégration des technologies d'IA dans les milieux d'affaires et, par le fait męme, dans la societe ; Appuyer les projets structurants visant l'adoption massive de l'IA dans une ou plusieurs filičres industrielles de la bioeconomie ; Soutenir la réalisation de projets débouchant sur des retombées économiques importantes et immédiates ; Assurer le développement et la consolidation d'efforts d'innovation en bioeconomie dans le domaine de l'IA ; Contribuer au positionnement du Québec comme chef de file en matičre de développement de l'IA dans les filičres industrielles de la bioeconomie

Quebec

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The EIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards. The EIA will support the research program of NHLBI-funded investigators for up to seven years. The EIA will provide investigators increased freedom to conduct research that breaks new ground or extends previous discoveries in new directions. It will also allow PD/PIs to take greater risks and to pursue research that requires a longer timeframe. Research supported by the EIA must be within the scope of the NHLBI mission (http://www.nhlbi.nih.gov/about/org/mission).

United States

Development and Characterization of Experimental models of post-TBI ADRD (R01 - Clinical Trial Not Allowed)

Goal is to have experimental models that can accurately reproduce neuropathological signatures and clinically relevant neurodegenerative, biochemical and behavioral sequelae as those seen in human subjects post-TBI AD/ADRDs. Requirement: Interdisciplinary Team science approach / consortium type of applications. Applications will include multiple sites (3-5 sites) developing and/or testing specific models that will then implement a test of reproducibility across the consortium. Requirement: Must have a clinician with expertise in post-TBI ADRD on the team. Encourage having neuropathologists as consultants on grants. Requirement: Models developed through this FOA will be required to share their model, model details and related standards with the VA-funded interagency preclinical resource center - PRECISE TBI Studies investigating neurodegeneration of white matter and chronic inflammation in post-TBI AD/ADRDs are highly encouraged. Innovative applications reaching beyond the current AD/ADRD models are highly encouraged.

United States

CleanBC Go Electric Commercial Vehicle Pilots (CVP) Program

Up to 75% funding for zero-emission commercial vehicles, infrastructure, and data collection.

Grant Goals - Accelerate commercial zero-emission vehicle (ZEV) technology adoption - Reduce transportation sector greenhouse gas emissions - Make zero-emission vehicles more affordable - Improve ZEV technology availability in British Columbia - Support CleanBC emission reduction targets - Gather operational data to inform long-term ZEV transition strategies Keywords - Zero-emission vehicles (ZEVs) - Commercial fleet electrification - Green transportation - Sustainable mobility - Emission reduction - Clean technology - Electric vehicles - Hydrogen fuel infrastructure - Low-carbon innovation - Transportation decarbonization - Fleet modernization - Sustainable infrastructure - Climate change mitigation - Clean energy transition - Vehicle electrification - Pilot program - Technological innovation - Emissions management - Sustainable business practices - Energy efficiency Description The Commercial Vehicle Pilots (CVP) Program supports British Columbia-based organizations in deploying zero-emission commercial vehicles and supporting infrastructure. By providing financial incentives and gathering operational insights, the program aims to accelerate the transition to clean transportation technologies across various vehicle classes and transportation modes. Target Audience - B.C.-based businesses - Non-profit organizations - Local governments - Indigenous communities - Public sector entities - Commercial fleet operators - Transportation service providers - Logistics companies - Municipal transportation departments - Regional transit authorities Eligible Expenses - Zero-emission vehicle purchases - Vehicle leasing - Electric charging infrastructure - Hydrogen fuelling infrastructure - Supporting technology deployment - Infrastructure installation - Charging station equipment - Vehicle modification costs Eligibility - Located and operating in British Columbia - Licensed B.C. business - Consortiums permitted - Public and private fleets - Non-provincial ministry organizations Criteria - Minimum vehicle deployment requirements - Vehicle weight class specifications - Infrastructure support conditions - Geographic focus on specific economic regions - Technological readiness - Emission reduction potential Program Requirements - Provide operational data - Deploy minimum vehicle quantities - Use approved zero-emission technologies - Implement supporting infrastructure - Comply with program guidelines - Submit required documentation Hiring Criteria - Not explicitly defined in source materials Due Dates - Not specified in source materials Start Dates - Not specified in source materials Age Requirements - No specific age restrictions mentioned Industry / Area of Work - Transportation - Logistics - Public transit - Municipal services - Freight - Marine transportation - Rail - Aviation - Off-road equipment - Construction - Utility services

British Columbia

FY23 Dept of Navy (DoN) Science Technology Engineering & Mathematics (STEM) Education and Workforce Program

This FOA is for STEM education programs and activities, which is formal or informal education that is primarily focused on physical and natural sciences, technology, engineering, social sciences, and mathematics disciplines, topics, or issues (including environmental science education or stewardship).. . STEM education programs and activities that could be supported by this FOA include one or more of the following as the primary objective:. . ‚Ģ Develop learners‚Äô knowledge, skill, or interest in STEM.. . ‚Ģ Attract students to pursue certifications, licenses, or degrees (two-year degrees through post-doctoral degrees) or careers in STEM fields.. . ‚Ģ Provide growth and research opportunities for post-secondary, college and graduate students in STEM fields, such as working with researchers or conducting research that is primarily intended to further education.. . ‚Ģ Improve mentor/educator (K-12 pre-service or in-service, post-secondary, and informal) quality in STEM areas.. . ‚Ģ Improve or expand the capacity of institutions to promote or foster STEM fields.. . This FOA will not consider applications for research, with the exception of those whose primary purpose is intended to further education (as described in third bullet above) and that are not expected to generate intellectual property. Efforts for research, including those supporting STEM, should be submitted under the current fiscal year Long Range BAA.. . Please see full text of the announcement for additional details.

United States

Soil Health Outreach in Utah

UPDATE:. . Guidance for preparing the SF424, SF424A, and Budget Narrative (Appendices A-C), have been uploaded to the Related Documents tab. The Full Announcement has been updated to include Appendices A-C and also can be found at the Related Documents Tab.. . . . . . . . Notice of Funding Opportunity Summary. . . . . The United States Department of Agriculture's, Natural Resources Conservation Service (The USDA, NRCS), has a Notice of Funding Opportunity for Competitive Cooperative Agreements focused on soil health outreach activities in Utah. The . . overall . . objective of this solicitation is to encourage the implementation of innovative projects that promote sustainable agricultural practices and the protection of natural resources, especially soil health. This objective is to be accomplished through educational, outreach activities that showcase, demonstrate, and disseminate innovative soil health practices and information. The successful applicant(s) will be responsible for organizing all aspects of the outreach events, both live in-person, and virtual.. . . . . NRCS values the role of partnerships in expanding soil health knowledge and practices with agricultural stakeholders, including historically underserved communities and socially disadvantaged farmers and ranchers. Outreach events supported by this solicitation will maximize engagement with Utah farmers, producers, ranchers, NRCS staff, and partners through workshops, conventions, field days, and trainings. Applicants are encouraged to seek keynote speakers, technical speakers, and champion farmers from nationally and internationally reputable scientists, farmers, producers, and university professors. The proposed events should involve collaboration with these stakeholders. . . . . . The USDA, NRCS is inviting proposals from experienced, eligible, non-federal entities that specialize in conducting workshops, conventions, field days, and trainings for Utah farmers, producers, ranchers, NRCS staff, and partners. . . Applications will be screened for completeness and compliance with the provisions of this notice. Incomplete and/or noncompliant applications may be eliminated from competition. Notification of proposal elimination due to an incomplete submission will be sent to the applicant. . . Proposals will be evaluated based on their ability to achieve measurable results, promote collaboration, and effectively use available resources. . . NRCS reserves the right not to fund any or all applications.. . . . . Agreements awarded pursuant to this solicitation may be 1-5 years in duration . . (January 1, 2024, to December 31, 2028). . . . . Proposed projects must be performed in Utah. Applicants may request up to $550,000 in funding. . . . . . For new users of Grants.gov, see Section D. for information about steps required before submitting an application via Grants.gov.. . . . .  . . . . . Key Dates. . . . . Applicants must submit their applications via Grants.gov by 11:59 pm Eastern Time on July 8, 2023. For technical issues with Grants.gov, contact Grants.gov Applicant Support at 1-800-518-4726 or support@grants.gov. Awarding agency staff cannot support applicants regarding Grants.gov accounts.. . . . . For inquiries specific to the content of the NFO requirements, contact the federal awarding agency contact (section G of this NFO). Please limit questions to those regarding specific information contained in this NFO (such as dates, page numbers, clarification of discrepancies, etc.). Questions related to eligibility, or the merits of a specific proposal will not be addressed.. . . . . The agency anticipates making selections by . . August 11, 2023 and. . expects to execute awards by September, 2023. These dates are estimates and are subject to change. 

United States

Increasing the Supply of Affordable Housing through Off-Site Construction and Pro-Housing Reforms Research Grant Program Pre and Full Application

This NOFO aims to support research that fills crucial knowledge gaps and help build the evidence base to accelerate the adoption of effective practices and policies to increase the production and supply of quality, affordable housing in the United States.Specifically, the purpose of this research grant program is: (1) to assess the potential for off-site construction methods to increase housing supply, lower the cost of construction and/or reduce housing expenses for low- and moderate-income owners and renters; and (2) to study how reforms to local zoning and other land-use regulations can increase the supply of quality, affordable housing and expand housing choices and opportunities for low- and moderate-income households.The Office of Policy Development and Research (PD&R) invites researchers from a broad range of disciplines—including but not limited to architecture, data science, economics, engineering, environmental science, finance, geography, law, planning, political science, public health, public policy, sociology and urban studies—to submit applications that clearly address HUD’s Strategic Objective 2A: Increase the Supply of Housing, which is available in HUD’s FY 2022-2026 Strategic Plan.Applicants will have the opportunity to select from the categories of research that are relevant to both the departmental Strategic Plan Goal 2A and relevant, housing supply-focused sections of HUD’s Learning Agenda. Applicants are also invited to submit proposals that address research questions listed in PD&R’s Offsite Construction for Housing: Research Roadmap. Applicants must clearly identify the priority research category (or categories) described below that their proposal addresses and clearly describe how their proposed research would make a valuable contribution to HUD’s Strategic Plan and Learning Agenda goals related to affordable housing supply.

United States

Evaluation of linkage to care programs in support of hepatitis C elimination

The Office of Infectious Disease and HIV/AIDS Policy (OIDP) anticipates funding a linkage to care intervention and evaluation project that demonstrates the effectiveness of streamlined linkage to hepatitis C treatment from settings with high prevalence of hepatitis C. The purpose of this initiative under the Public Health Service Evaluation Fund is to implement and evaluate hepatitis C community navigation and linkage to care interventions. Interventions of interest are those that are likely to improve hepatitis C treatment rates, reduce transmission, reduce hepatitis C disparities, and reduce hepatitis C-related liver cancer and mortality among people who are disproportionately impacted by viral hepatitis. Examples of settings with high prevalence of hepatitis C may include correctional settings or harm reduction programs. Recipients will work with community partners to implement and evaluate interventions and develop resources for dissemination to diverse stakeholders.   

United States

Technology Acceleration Program 2025-2026

Supports cleantech SMEs in advancing through Technology Readiness Levels to achieve milestones that drive enterprise value.

Canada

Zero Emission Vehicle Awareness Initiative

75% funding for ZEV education, outreach, and charging infrastructure projects.

The Zero Emission Vehicle Awareness Initiative (ZEVAI) aims to support projects and organizations that spread awareness of and increase public confidence in zero-emission vehicles, as well as public charging and refuelling infrastructure. The ZEVAI is particularly geared to fund outreach, education, and capacity-building activities. ?There are two streams under the ZEVAI:Light-duty Vehicle StreamThis stream is currently closed.Medium-and Heavy-duty Vehicle StreamThis stream is currently closed.Indigenous-led Projects Pilot StreamThis stream is currently open.Education and Awareness - Clean Transportation and Clean Fuels Stream: This stream is currently open

Canada

Zero Emission Vehicle Awareness Initiative – Light-Duty Vehicle – Not-for-profit

75% funding for electric vehicle charging and clean fuels awareness projects.

The objective is to support projects that address gaps in awareness, knowledge and public and industry confidence in zero-emission vehicles (ZEVs) of all classes, lower-emission medium and heavy-duty vehicle options, and clean fuels.

Canada

Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R01 Clinical Trial Optional)

The National Human Genome Research Institute intends to issue a Notice of Funding Opportunity (NOFO) to solicit applications that stimulate innovation and advance understanding of when, where and how best to implement the use and sharing of genomic information and technologies in clinical care in all persons including populations or communities that experience health disparities, such as racial or ethnic minority groups, people with lower socioeconomic (SES) status, underserved rural communities, and sexual and gender minority groups.. The intended NOFO will be based on aÔř?concept recently approved by the National Advisory Council on Human Genome Research and accompanyingÔř?discussion.. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.Ôř?. The NOFO is expected to be published in the spring of 2023 with an expected application due date in the fall of 2023.. This NOFO will utilize the the R01 activity code. Details of the planned NOFO are provided below.

United States

OMIF – Music Industry Initiatives

50% funding for professional development, networking, and market development in music.

MII provides funding to support Ontario's established music trade associations and music service organizations in offering initiatives, events, and activities aimed at strengthening, supporting, and stimulating the economic and cultural growth of Ontario's music industry.

Ontario

Yukon Tourism Training Fund

75% funding for training in First Aid, marketing, guiding, and more.

The Yukon Tourism Training Fund can pay for up to 75% of training costs for individuals or groups.

Yukon